Lake Shore Gazette

Leading News Website

The Dermatophytic Onychomycosis Therapeutics Market To Be Led By The Global

The global dermatophytic onychomycosis therapeutics (DOT) market is anticipated to expand at a healthy CAGR of around 7% during the forecast period. The market is expected to be worth US$ 8.9 Bn by the end of this decade, increasing from US$ 4.6 Bn in 2021.

By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR during the forecast period.

Get Going With Sample Of Dermatophytic Onychomycosis Therapeutics Market Report! https://www.persistencemarketresearch.com/samples/5840                    

By treatment, the market is segmented into topical and oral therapy. Among these, the topical segment is anticipated to be dominant throughout the forecast period and projected to account for over 3/5 share of the total global dermatophytic onychomycosis market revenue by 2021.

By distribution channels, the market is segmented into hospitals, dermatology and podiatry clinics, independent pharmacies, mail order pharmacies, and drug stores. Among these, drug stores are estimated to be largest segment with 2/5 share of the total global market revenue by 2021-end.

The drug stores segment is expected to register the fastest CAGR during the forecast period. Independent pharmacies are projected to be the second most attractive segment of the global dermatophytic onychomycosis therapeutics market by 2021-end.

Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs.

However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin America are expected to impede growth of the global dermatophytic onychomycosis therapeutics market.

How About Re-Inventing The Methodical Wheel In The Dermatophytic Onychomycosis Therapeutics Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.com/methodology/5840               

This report covers global and regional trends along with an analysis of the market potential. North America is expected to account for nearly 50% revenue share of the total dermatophytic onychomycosis therapeutics market by 2021-end, i.e. holding the maximum market share. Whereas Europe is projected to grow at a healthy CAGR due to increasing awareness about fungal nail infections.

Global dermatophytic onychomycosis therapeutics market report begins with an overview of the global market in terms of value. This section includes detailed analysis of key trends, drivers and restraints, and opportunities.

All of these are factors that impact market growth. Impact analysis of key growth drivers and restraints based on the weighted average of each one of these factors in a model-based approach is included in the market report to better equip clients with crystal clear decision-making insights.

Key players of the global DOT market include Galderma S.A., Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Janssen Pharmaceuticals, and others. Leading companies in this market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.

Keeping A Tab On Key Players In The Dermatophytic Onychomycosis Therapeutics Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Dermatophytic Onychomycosis Therapeutics Market Report! https://www.persistencemarketresearch.com/checkout/5840         

Browse the full Dermatophytic Onychomycosis Therapeutics Market: Global Industry Analysis and Forecast, 2021-2031 at http://www.persistencemarketresearch.com/market-research/dermatophytic-onychomycosis-therapeutics-market.asp

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

Persistence Market Research stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, Persistence Market Research’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact

Addie Thomas

305 Broadway

7th Floor

New York City, NY 10007

US

USA – Canada Toll Free: 800-961-0353

Email: info@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *